Vitamin B-12-fortified toothpaste improves vitamin status in vegans: a 12-wk randomized placebo-controlled study

Am J Clin Nutr. 2017 Mar;105(3):618-625. doi: 10.3945/ajcn.116.141978. Epub 2017 Jan 4.

Abstract

Background: The oral application of vitamin B-12 may prevent its deficiency if the vitamin is absorbed via the mucosal barrier.Objectives: We studied the effect of the use of a vitamin B-12-fortified toothpaste on vitamin-status markers in vegans and assessed the efficiency of markers in the identification of vitamin-augmentation status.Design: In this 12-wk, double-blinded, randomized, placebo-controlled study, 76 vegans received either a placebo (n = 34) or vitamin B-12 (n = 42) toothpaste. Sixty-six subjects (n = 30 in the placebo arm; n = 36 in the vitamin B-12 arm) completed the intervention. Serum and plasma concentrations of vitamin B-12, holotranscobalamin, total homocysteine (tHcy), and methylmalonic acid (MMA) were measured before and after the intervention.Results: Both postintervention concentrations of vitamin B-12 and holotranscobalamin and their changes over 12 wk were higher in the vitamin B-12 group (mean ± SD change: 81 ± 135 pmol/L for vitamin B-12 and 26 ± 34 pmol/L for holotranscobalamin) than in the placebo group (-27 ± 64 and -5 ± 17 pmol/L, respectively) after adjustment for baseline concentrations. Postintervention concentrations of MMA and their changes differed significantly between groups (MMA changes: -0.169 ± 0.340 compared with -0.036 ± 0.544 μmol/L in vitamin B-12 and placebo groups, respectively; P < 0.001). After adjustment for baseline tHcy, postintervention concentrations of tHcy tended to be lower (P = 0.051), and the changes in tHcy (-0.7 ± 4.4 compared with 2.0 ± 5.6 μmol/L, respectively) were greater in the vitamin B-12 group than in the placebo group. Changes in vitamin B-12 markers were more prominent in vegans who reported that they had not taken vitamin B-12 supplements.Conclusion: Vitamin B-12 that is applied to the oral cavity via toothpaste enters the circulation and corrects the vitamin B-12 markers in the blood of vegans who are at higher risk of vitamin B-12 deficiency. This trial was registered at clinicaltrials.gov as NCT02679833.

Keywords: deficiency; holotranscobalamin; methylmalonic acid; supplementation; vegans; vitamin B-12.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Double-Blind Method
  • Female
  • Homocysteine / blood
  • Humans
  • Male
  • Methylmalonic Acid / blood
  • Mouth Mucosa / metabolism*
  • Nutritional Status*
  • Toothpastes*
  • Transcobalamins / metabolism
  • Vegans*
  • Vitamin B 12 / blood
  • Vitamin B 12 / pharmacokinetics
  • Vitamin B 12 / pharmacology*
  • Vitamin B 12 Deficiency / blood
  • Vitamin B 12 Deficiency / prevention & control*
  • Vitamin B Complex / blood
  • Vitamin B Complex / pharmacokinetics
  • Vitamin B Complex / pharmacology*
  • Young Adult

Substances

  • Biomarkers
  • Toothpastes
  • Transcobalamins
  • Homocysteine
  • Vitamin B Complex
  • Methylmalonic Acid
  • Vitamin B 12

Associated data

  • ClinicalTrials.gov/NCT02679833